Clinical trials, between science and financial and academic interests
Pierre Chirac
The Crash team was delighted to welcome Pierre Chirac, pharmacist and editor of the magazine Prescrire, for a conference on his analysis of the pharmaceutical industry's influence strategies and the special interests of university hospital researchers, their consequences on the reliability of drug information and the means now required to rectify a harmful situation. This meetting was prepared and moderated by Rony Brauman.
On May 22, the Lancet published a peer-reviewed article based on an analysis of 96,000 Covid patient files, which concluded that hydroxychloroquine was ineffective. A few days later, researchers published a letter questioning the methodology and data used by the Surgisphere company to develop this conclusion, and on June 4, the Lancet withdrew the article from publication. This was the beginning of what some people call "Lancetgate", or the "Surgisphere Scandal".
Beyond the frenzy of scientific publications triggered by the Covid-19 outbreak (47,000 in three months!), this event highlighted the questionable reliability of clinical trials. In September 2009, the scientific journal PloS Medicine argued that most trials of new drugs, including those supposedly authored by academic physicians, are subject to frequent manipulation. The title of their editorial clearly indicates scorn: Ghostwriting: The Dirty Little Secret of Medical Publishing That Just Got Bigger, and the piece specifically outlines the influence and power of drug manufacturers in the clinical research process. Yet the poor quality studies published by French hospital doctors on hydroxychloroquine, even with no link to pharmaceutical companies, show that the problem goes far beyond that of trials financed by 'Big Pharma'.
To cite this content :
Pierre Chirac, “Clinical trials, between science and financial and academic interests”, 8 octobre 2020, URL : https://msf-crash.org/en/conferences-debates/clinical-trials-between-science-and-financial-and-academic-interests
If you would like to comment on this article, you can find us on social media or contact us here:
Contribute
Daro Sulakauri
Opinion
No credit for Drs Knock
12/01/2009Pharmaceutical companies produce drugs and are increasing involved in the clinical trials of these products. This conflict of interest is incompatible with the expectations of Public Health. Rony Brauman suggests that the industry no longer be responsible for therapeutic trials.
Giorgos Moutafis
Analysis
Postface à l’ouvrage "Médiator 150mg"
06/30/2010Ce texte est une postface au livre du Dr Irène Frachon Médiator, 150mg dont le sous-titre « Combien de morts ?», a été retiré à la suite d'une plainte du laboratoire Servier, producteur du médicaments incriminé. Rony Brauman y aborde la question du poids croissant des compagnies pharmaceutiques dans les décisions de santé publique.
Aurelie Baumel
Interview
Santé mondiale. L’évolution vers la privatisation
12/01/2014Pour Rony Brauman, la question de la santé globale se caractérise d'abord et avant tout par la circulation des agents infectieux et toxiques qui relève d'une action mondiale.
Past events
Roger Job
Conference
France in Rwanda. Guilty neutrality
02/11/2019 - 06:00 PM 08:00 PMThe CRASH team invited you to the screening-debate “France in Rwanda. Guilty neutrality” on Monday 11th of February 2019 from 6 to 8pm, in the 1rst floor room of the 8 rue Saint-Sabin. A documentary film by Robert Genoud and Claudine Vidal (Director Emeritus for research at the CNRS, member of the CRASH scientific committee at MSF), and produced by EUP. Before and after the screening, Claudine Vidal and Jean-Hervé Bradol, both actors of MSF mobilization between 1994 and 1998 launched the discussion.
Conference
Healing foreigners in France: The State and the civil society organisations from the 80s to the 90s
12/17/2018 - 06:00 PM 08:00 PMThe CRASH team invited you to the debate-conference “Healing foreigners in France: The State and the civil society organisations from the 80s to the 90s” on Monday 17th of December 2018. We hosted Caroline Izambert, who recently defended, at the EHESS, her PhD thesis focusing on the foreigners’ access to healthcare in France. Her title: “Heal foreigners?” The State and the civil society organisations for the health coverage of the poor and foreigners in France from the 1980s to the present day. This conference was prepared and moderated by Michaël Neuman.
Conference
Borders and Hospitality
11/26/2018 - 06:00 PM 08:00 PMThe Crash team had the pleasure of welcoming Benjamin Boudou, politician and researcher at the Max Planck Institute, for a conference-debate on November 26, 2018. The meeting was prepared and moderated by Michaël Neuman.
MSF-Crash
Conference
Immunization: new perspectives on vaccines - Conference with Lise Barnéoud
12/05/2017 - 06:00 PM 08:00 PMLise Barnéoud was a Crash guest speaker at a conference on vaccination held on December 5, 2017. A discussion with Epicentre, Crash and the MSF Medical Department allowed us to exchange views on vaccinal policy, which remains a cornerstone of MSF operations and a recurring subject of discussion and controversy. This meeting was prepared and moderated by Michaël Neuman and Emmanuel Baron.
MSF
Conference
Humanitarian anthropology : conference with Sharon Abramowitz
10/23/2017 - 06:00 PM 08:00 PMThe Crash team had the pleasure of welcoming Sharon Abramowitz, American medical anthropologist and author of "Medical Humanitarianism: Ethnographies of Practice", for a conference-debate on October 23, 2017. The meeting was prepared and moderated by Michaël Neuman.
Conference
Eyal Weizman - Forensic Architecture at work
02/15/2016 - 07:00 PM 09:30 PMEyal Weizman, founder of Forensic Architecture at Goldsmiths College, University of London, presented his project and a number of his achievements at a Crash conference held on July 2, 2015. The event was organized and moderated by Michaël Neuman.